RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding RenovoRx, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 25 | 31 | +6 |
| Shares | 8.79M | 7.13M | −1.66M (−18.9%) |
| Value | $11.6M | $9.04M | −$2.54M (−22.0%) |
New holders (8)
Institutions that held RenovoRx, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 121,341 | $154.1K | 0.00% |
| XTX Topco Ltd | 31,615 | $40.2K | 0.00% |
| FNY Investment Advisers, LLC | 16,000 | $20.0K | 0.01% |
| Jane Street Group, LLC | 13,759 | $17.5K | 0.00% |
| Citigroup Inc | 3,060 | $3.89K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,589 | $2.02K | 0.00% |
| Barclays PLC | 118 | $150 | 0.00% |
| SBI Securities Co., Ltd. | 2 | $3 | 0.00% |
Sold out (2)
Institutions that held RenovoRx, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Two Sigma Securities, LLC | 21,835 | $28.7K |
| ADAR1 Capital Management, LLC | 19,889 | $26.2K |